Please Note: The conference will be held in Eastern Daylight Time (EDT)
This conference will provide up-to-date overviews and discussions of advances in the field of psychedelics and psychedelic-assisted therapies, with an emphasis on clinical studies and practice. Mechanisms of action including pharmacology, neuroscience, and psychodynamic theory will be discussed, with a focus on specific clinical entities such as depression, PTSD, and addictions. Additional panel discussions and presentations will explore history, ethics, cultural issues, plant medicine, and many other relevant topics within the rapidly growing field of psychedelic medicine.
You will receive an email communication (to the email registered to your MGH Psychiatry Academy account) as we get closer to the conference date with details on the zoom instructions and attending virtually.
MDs/Doctoral-Level Professionals:
Super Early Bird (on or before August 15, 2025): $475.00
Early Bird (on or before October 3, 2025): $525.00
Regular Registration (after October 3, 2025): $550.00
Other Clinicians:
Super Early Bird (on or before August 15, 2025): $350.00
Early Bird (on or before October 3, 2025): $400.00
Regular Registration (after October 3, 2025): $425.00
Other Professionals: $150.00
Trainees/Students: $100.00
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
Livestream Troubleshooting Tips.pdf
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 3, 2025. No refunds will be issued for refund requests made after October 3, 2025. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
This program is designed for clinicians and researchers across various disciplines who are interested in deepening their understanding of psychedelics, both theoretically and practically. It is open to mental health practitioners such as psychiatrists, psychiatric nurse practitioners, social workers, and clinical psychologists, as well as professionals from other fields who are curious about the applications of psychedelics in clinical and research settings.
Please come back later for this information.
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
10.0 Psychologists
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. MGH Institute of Health Professions designates this activity for 10.0 CE credit.
10.0 Physicians
MGH Institute of Health Professions designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
10.0 Physician Associates/Assistants
MGH Institute of Health Professions has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
10.0 Nursing
MGH Institute of Health Professions designates this activity for 10.0 contact hours for nurses.
10.0 Social Workers
As a Jointly Accredited Organization, the MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 10.0 clock hours for continuing education credits.
10.0 Pharmacist (ACPE)
This activity provides 10.0 contact hours (1.0 CEUs) of continuing education credit. ACPE Universal Activity Number UAN JA4008265-0000-24-000-L04-P
NOTE FOR PHARMACISTS: Upon closing of the electronic evaluation, MGH IHP will upload the pharmacy-related continuing education information to CPE Monitor within 60 days. Per ACPE rules, MGH IHP does not have access or the ability to upload credits requested after the evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP ePID and DOB (in MMDD format)] in order to receive credit for participating in a CE activity.
10.0 IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 10.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
5th Annual Conference on Psychedelics & Psychedelic Medicine
Virtual
November 14-15, 2025
Agenda
Day 1 – November 14, 2025
8:30-8:40 AM Welcome & Introduction
Franklin King, MD
MODULE TOPIC 1: Foundations of Psychedelic Research and Practice
8:40–9:00 AM History & Pharmacology of Psychedelics Basics
Franklin King, MD
9:00-9:40 AM Keynote: State of Psychedelic Research in 2025
David Yaden, PhD
9:40-10:00 AM Panel Discussion
Moderator: Jerrold Rosenbaum, MD
Panelist: David Yaden, PhD
10:00-10:15 AM Break
MODULE TOPIC 2: The Neuroscience of Psychedelics
10:15-10:35 AM Advancing the Cognitive Neuroscience of Psychedelics
Sharmin Ghaznavi, MD, PhD
10:35-10:55 AM Beyond the Trip: Classifying Psychedelic Compounds Through Neural Signatures
Alfred Kaye, MD, PhD
10:55-11:25 AM Panel Discussion Moderator: Bruce Rosen, MD
Panelist: Sharmin Ghaznavi, MD, PhD; Alfred Kaye, MD, PhD
MODULE TOPIC 3: Novel Entheogenic Compounds, Natural and Synthetic
11:25-11:45 AM From Nature to Neuroscience: Novel Plant-Derived Psychedelics & Modeling Human Brain Plasticity with Neurons & Organoids
Stephen Haggarty, PhD
11:45-12:05 PM Synthetic Cathinones and PTSD: Investigating Novel Empathogenic Compounds Beyond Psychedelics
Ben Kelmendi, MD
12:05-12:25 PM Progress in Novel Entactogens as Therapeutics
Matthew Baggott, PhD
12:25-12:55 PM Panel Discussion
Moderator: Jerrold Rosenbaum, MD
Panelists: Stephen Haggarty, PhD; Matthew Baggott, PhD
12:55-1:00 PM Closing Remarks
Franklin King, MD
Day 2 – November 15, 2025
9:00-9:05 AM Welcome & Introduction
Franklin King, MD
MODULE TOPIC 4: Clinical Frontiers & Ethical Tensions in Psychedelic Psychiatry
9:05-9:25 AM Psychedelics & Addictions, from Ketamine to Ibogaine
Joji Suzuki, MD
9:25-9:45 AM Balancing Risk, Harm & Autonomy: An Ethical Perspective on Psychedelic Research
Brian Earp, PhD
9:45-10:05 AM Mood Disorders & Psychedelics: Update on Psychedelic Research for Depression and Bipolar Disorders
Natalie Gukasyan, MD
10:05-10:35 AM Panel Discussion
Moderator: Franklin King, MD
Panelists: Joji Suzuki, MD; Brian Earp, PhD; Natalie Gukasyan, MD
10:35-10:50 AM Break
MODULE TOPIC 5: Implementation in Healthcare Settings: Insurance, Reimbursement & Medical Populations
10:50-11:10 AM Navigating Insurance & Reimbursement Pathways in Psychedelic Therapy
Brian Barnett, MD
11:10-11:30 AM Ketamine in the General Hospital
Cristina Cusin, MD
11:30-11:50 AM Psychedelics in Medical Populations: Perspective from a Study of Psilocybin-Assisted Therapy for Irritable Bowel Syndrome
Erin Mauney, MD
11:50-12:20 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Brian Barnett, MD; Cristina Cusin, MD; Erin Mauney, MD
12:20-1:20 PM Lunch Break
MODULE TOPIC 6: Perspectives on Psychedelic-Assisted Therapy
1:20-1:40 PM On the Differences & Similarities of Working with Patients Using MDMA & Psilocybin
Kelley O’Donnell, MD, PhD
1:40-2:00 PM Psychedelics in Death & Dying
Yvan Beaussant, MD
2:00-2:20 PM Psychedelic-Assisted Therapy: Challenges of Capturing the Nuance
Roxanne Sholevar, MD
2:20-2:50 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Kelley O’Donnell, MD, PhD; Yvan Beaussant, MD; Roxanne Sholevar, MD
2:50-3:05 PM Break
MODULE TOPIC 7: Rules of the Game: Redefining Evidence, Access & Legality in Psychedelic Science
3:05-3:25 PM Policy & Law in Psychedelics: Navigating Evolving Frameworks
Allison Hoots, JD
3:25-3:45 PM Laboratory of the Future? Australia’s prescription psychedelic rollout and other innovations in the Land of Oz
Paul Liknaitzky, PhD
3:45-4:05 PM Challenges of Placebo Control in Psychedelic RCTs
Balázs Szigeti, PhD
4:05-4:35 PM Panel Discussion
Moderator: Franklin King, MD
Panelists: Allison Hoots, JD; Paul Liknaitzky, PhD; Balázs Szigeti, PhD
4:35-4:45 PM Closing Remarks
Franklin King, MD
Franklin King, MD
Director, Training and Education, Center for Neuroscience of Psychedelics, Massachusetts General Hospital
Instructor in Psychiatry, Harvard Medical School
Franklin King, MD
David Yaden, PhD
Jerrold Rosenbaum, MD
Alfred Kaye, MD, PhD
Brian Barnett, MD
Cristina Cusin, MD
Erin Mauney, MD
Kelley O’Donnell, MD, PhD
Brian Earp, PhD
Balázs Szigeti, PhD
Roxanne Sholevar, MD
Allison Hoots, JD
Natalie Gukasyan, MD
Sharmin Ghaznavi, MD, PhD
Bruce Rosen, MD
Joji Suzuki, MD
Yvan Beaussant, MD
Paul Liknaitzky, PhD
Stephen Haggarty, PhD
Ben Kelmendi, MD
Matthew Baggott, PhD
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this live activity for a maximum of 10.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 10.00 contact hours of nursing continuing education credit.
Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 10.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR.
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists.
The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content. This offering meets the criteria for 10.00 Continuing Education (CE) credits per presentation for psychologists.
We have a dedicated staff member who is available by phone 5 days per week between 8 am and 5 pm by calling 866-644-7792 or email at mghcme@mgh.harvard.edu. All inquiries will be dealt with in a timely (within one business day) and professional manner. Requests for credits or refunds will be reviewed by the Director of the Division of Professional and Public Education, Massachusetts General Hospital. Please refer to our cancellation policy for additional information.”